Table 3 |
||||
|
Multivariate Cox regression analysis |
||||
|
Variable |
Hazard ratio |
95% Confidence interval |
P value |
|
|
|
||||
|
Lower limit |
Upper limit |
|||
|
|
||||
|
pre-op PSA < 5 ng/ml |
0.683 |
0.155 |
2.681 |
0.766 |
|
|
||||
|
pre-op PSA 5-10 ng/ml |
0.838 |
0.262 |
3.013 |
0.639 |
|
|
||||
|
pre-op PSA > 10 ng/ml |
1.463 |
0.332 |
6.449 |
0.615 |
|
|
||||
|
Gleason score |
1.448 |
0.586 |
3.581 |
0.423 |
|
|
||||
|
pT stage |
3.354 |
1.342 |
8.386 |
0.010 |
|
|
||||
|
p16 |
0.643 |
0.260 |
1.592 |
0.340 |
|
|
||||
|
p27 |
1.065 |
0.403 |
2.813 |
0.899 |
|
|
||||
|
pre-op PSA, pre-operative PSA; pT stage, pathologic TNM stage |
||||
|
Vlachostergios et al. Journal of Negative Results in BioMedicine 2012 11:2 doi:10.1186/1477-5751-11-2 |
||||
